Awards as Co-PI
| Early Translational III | Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
| Early Translational III | Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
© 2013 California Institute for Regenerative Medicine